Delivery Order SPE2DR25D1106-SPE2DR26FJS0G

<p>The Defense Logistics Agency issued a $1,837.20 delivery order to AmerisourceBergen Drug Corp on February 25, 2026, for RHOPHYLAC 300 MCG/2 ML syringe product supply.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 18, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a $1,434.00 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rhophylac 300 mcg/2 mL syringes, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...

The Defense Logistics Agency awarded a $1,147.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under a larger contract vehicle. This delivery order is issued under...

The Defense Logistics Agency awarded a $1,434.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 MCG/2 ML syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a pediatric immunoglobulin product sourced through AmerisourceBergen's extensive federal pharmaceutical supply network. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...

The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,388.40 for Rhophylac 300 mcg/2 mL syringes under a firm fixed price contract. The award, issued December 31, 2025, with completion targeted for January 23, 2026, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...

The U.S. Defense Logistics Agency (DLA) awarded a $1,010.54 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4565418078 - RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $1,377.03 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...

This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies to the Defense Logistics Agency (DLA). The $1,836.04 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 13, 2024, with a completion date of September 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $1,720.80 and a firm fixed price structure. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will be completed by October 10, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...